EPGL Med ?@EPGLMed35m Have to Be Able to Do More

New Post Public Reply Private Reply Replies (0) Message Board
Badali

  • Have to Be Able to Do More Procedures. EPGL is Right There with Our Innovation Strategy." Dr. Markus Added.

  • with New and Innovative Design that is Advanced Technology. In Coming Years, there Will Be a Doctor Shortage. More Doctors Will...

  • Which Creates Valuable Products." Says David T. Markus PhD, VP BioMEMS Development. "We are attacking the Intellectual Property Strategy...

  • of a Research Company as a Medical Device Company. Ideas create Intellectual Property...

  • EPGL Engineers Continue to Acquire an Impressive Array of Intellectual Property for New Device Technology. "We view our Company as much...

  • EP Global Communications Inc. (EPGL) Stock Research Links

    EPGL Board Company Profile Buy Rating Time & Sales News Filings Financials
    Scroll down for more posts ▼

    Top 10 Most Recent News Articles

    Top 5 Most Recently Viewed Articles

    Zhihu Inc.'s Share Units Grant: Incentives and Performance Insights

    Updated Category News Views 54

    Zhihu Inc. Issues Restricted Share Units to Enhance Employee Incentives Zhihu Inc. (NYSE:ZH), a prominent online content community, recently disclosed an important development concerning its employee incentive programs. The company has issued restricted share units, aligning with its 2022 Share Incentive Plan, as documented in a Form 6-K filed with the Securities and...

    Continue Reading
    How to Make the Cash in Your Investment Portfolio Work Harder

    Updated Category Investing Views 114

    Ask most investors where their money sits and they will describe their equity positions in detail. Ask about the cash and the answer gets vague fast. That cash is usually the least examined line on the whole balance sheet. It is also, for a lot of people, a meaningful share of net worth sitting somewhere that was chosen years ago and never revisited. Cash is not the...

    Continue Reading
    Novo Nordisk's amycretin Moves to Phase 3 for Weight Management

    Updated Category News Views 546

    Advancements in Obesity Treatment by Novo Nordisk In the quest for effective obesity treatments, Novo Nordisk has made significant strides with their investigational drug, amycretin. This novel therapy aims to assist individuals struggling with obesity by targeting appetite regulation. Recent results from early-phase clinical trials have been published, showcasing...

    Continue Reading
    Shell's Challenge in Finalizing the German Refinery Deal

    Updated Category News Views 133

    Shell Faces Challenges in Selling the Schwedt Refinery Shell is currently encountering significant delays in its efforts to sell a stake in the Schwedt refinery. A number of pending lawsuits from third parties are largely responsible for this situation, placing a long-anticipated divestment on hold. The Schwedt refinery is vital for fuel supply, and this contentious sale...

    Continue Reading
    Stock Images Market Poised for Growth with Increasing Demand

    Updated Category News Views 319

    Exploring the Growth of the Stock Images Market The stock images market is experiencing a promising expansion, with estimates that it will grow by USD 1.28 billion between 2025 and 2029. This growth is driven by the increasing need for high-quality imagery for various applications, fostering a continually evolving market landscape. Market Segmentation Insights...

    Continue Reading